NEW YORK, Sept. 17, 2019 /PRNewswire/ -- Decision Resources Group (DRG), www.decisionresourcesgroup.com, a premier provider of high-value data, analytics and insights

NEW YORK, Sept. 17, 2019 /PRNewswire/ -- TrialSpark, a technology company committed to improving the speed, access, and reliability of clinical trials, and Pfizer have entered into a multi-year collaboration to extend Pfizer clinical trials to community doctors who have not previously been study investigators. TrialSpark partners with doctors to create GCP/ICH-compliant

PRINCETON, N.J., Sept. 17, 2019 /PRNewswire/ -- The WIRB-Copernicus Group®'s (WCG™) Clinical Services Division is pleased to announce that enrollment in WCG KMR Group's 2019 Clinical Tri

RIVERVIEW, Fla., Sept. 17, 2019 /PRNewswire/ -- Senior Helpers®, one of the nation's premier providers of in-home senior care, today announced its Hillsborough locatio

CUPERTINO, Calif., Sept. 17, 2019 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has completed the Phase 2a clinical trial of its lead product candidate, DUR-

HORSHAM, Pa., Sept. 17, 2019 /PRNewswire/ -- Biocoat, Inc., a specialty manufacturer of hydrophilic biomaterial coatings for medical devices, today announced that the company has launched an ISO-certified, full-service on-site facility for the application of its HYDAK® coatings to its customers unique medical devices. Prior to the

BOSTON, Sept. 17, 2019 /PRNewswire/ -- Seniorlink, Inc., a leading tech-enabled health services company, is pleased to announce a Virtual Care Team pilot with leading health and well-be

SAN DIEGO, Sept. 17, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has named AnaBios the recipient of a grant to further develop its unique drug discovery platform utilizing muscle cells from the human heart (cardiomyocytes).  Funds from the grant will be used to develop a preclinical biomarker to identify the pro-arrhythmia risk of potential

SALT LAKE CITY, Sept. 17, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that D

BALTIMORE, Sept. 17, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S. dealers, ann